Delivery formulations

Catching up with LGM Pharma ahead of CPhI North America to find out about its pipeline

19-Apr-2024 By Liza Laws

LGM Pharma is a leading CDMO provider of comprehensive API sourcing and drug product contract development and manufacturing solutions to the pharmaceutical, biotechnology, and compounding pharmacy industries.

Production of tree-saving transformative vaccine adjuvant with in-lab plants

17-Apr-2024 By Liza Laws

During DCAT this year, CEO Gaston Salinas from Botanical Solution Inc., (BSI), sat down with Liza Laws, the senior editor of OSP and BPR to discuss his company’s pioneering work in revolutionizing vaccine adjuvant production.

DCAT

DCAT Debrief: Lonza's perspective on pharma's path forward with AI and drug development

16-Apr-2024 By Liza Laws

In a recent discussion with Jan Vertommen, vice president and head of commercial development for the small molecules division at Lonza, key insights were shared regarding the pharmaceutical industry's current landscape and future trajectory.

Adragos Pharma - poised to make a lasting impact in the pharmaceutical industry

11-Apr-2024 By Liza Laws

Adragos Pharma is a contract development and manufacturing organization (CDMO) that provides development and manufacturing services for drug products. It concentrates on small molecule dosage forms including sterile and non-sterile liquids, solids, and...

Pluss unveils Celsure XL VIP pallets - a game-changer for the pharma industry?

03-Apr-2024 By Liza Laws

Pluss, a leading provider of temperature-controlled packaging solutions, today (April 3) launched its latest innovation, the Celsure XL VIP pallets.

Drug discovery and global player, Cresset, moves team into Boston marking major turning point

12-Mar-2024 By Liza Laws

Greater integration is to take place between the US and UK following an expansion says Cresset, a provider of integrated in-silico solutions for drug discovery.

Webinar: Innovations in drug delivery - tune in and join our excellent panel

27-Feb-2024 By Liza Laws

As the landscape of healthcare continues to evolve, so too does the field of drug delivery.

AstraZeneca’s Tagrisso that delays lung disease progression by nine months gets FDA approval

19-Feb-2024 By Liza Laws

Patients in the US with epidermal growth factor receptor mutated (EGFRm) advanced lung cancer can now receive an important new treatment option delaying disease progression by nearly nine additional months.

dsm-firmenich and Zerion Pharma partnership will focus on patient centric CBD formulations

15-Feb-2024 By Liza Laws

dsm-firmenich, today (February 15) announces its exclusive partnership with Zerion Pharma A/S to unlock a new era in cannabinoid innovation that champions patient-centric formulations.

Startup founded to help an 'NHS in crisis' by creating digital clinics accessed as easily as online banking

01-Feb-2024 By Liza Laws

A husband-and-wife team keen to find a solution to an ‘NHS in crisis’ have secured $1.5 million in seed funding for their UK-based startup providing AI-powered clinical and drug prescription services for minor conditions.

Stevanato Group tackling flexible drug containment packages and filling solutions

30-Jan-2024 By Liza Laws

Two new offerings have been unveiled by drug delivery and solutions provider, Stevanto Group S.p.A.

Aversa Fentanyl combines abuse-deterrent transdermal technology with fentanyl patch system

15-Jan-2024 By Liza Laws

Access to opioids such as fentanyl can lead to abuse but now two companies have signed an agreement to reduce the abuse potential while making sure they are still accessible to those who need them.

Cormica Bradford expanding equipment range to update capabilities

15-Jan-2024 By Liza Laws

Cormica Bradford, a division of Cormica says it is proud to announce a significant expansion of its laboratory capabilities.

Roquette and Qualicaps combine to expand global footprint

08-Dec-2023 By Liza Laws

Pharma and plant-based ingredient giant, Roquette, has confirmed its acquisition of Qualicaps from the Mitsubishu Chemical Group.

Symbiosis Pharmaceutical Services granted MHRA license following £1 million investment

07-Dec-2023 By Liza Laws

Symbiosis Pharmaceutical Services can now test small molecule, biological and advanced therapeutical medicinal products (ATMP) following a £1 million investment.

Piramal Pharma has launched a high-throughput screening facility

06-Dec-2023 By Liza Laws

Piramal Pharma has launched a high-throughput screening facility at its drug discovery services site in Ahmedabad, India.

Lilly's plans for $2.5 billion site in Germany to expand injectable manufacturing capacity

06-Dec-2023 By Liza Laws

Eli Lilly has invested in its manufacturing capacity once more and has announced plans to build a $2.5 billion high-tech manufacturing site in Germany.

CellCentric's new ways to treat specific blood cancers published in Cancer Cell journal

22-Nov-2023 By Liza Laws

A cornerstone paper published in peer-reviewed scientific journal, Cancer Cell, has demonstrated a new way to treat specific blood cancers.

Pfizer's first acute migraine treatment recommended by NICE

28-Sep-2023 By Liza Laws

The first treatment for acute migraine made by Pfizer Ltd has been recommended by the National Institute for Health and Care Excellence (NICE).

GSK’s Ojjaara approved by FDA for patients with blood cancer and anemia

18-Sep-2023 By Jonathan Smith

The small molecule drug Ojjaara (momelotinib), developed by GlaxoSmithKline, has become the first U.S. Food and Drug Administration (FDA)-approved treatment for patients with the blood cancer myelofibrosis and anemia.

Calliditas Therapeutics advances kidney disease drug, meeting primary endpoint in study

15-Aug-2023 By Liza Laws

Calliditas Therapeutics AB’s phase 3 study looking at a cure for a kidney disease called IgA nephropathy (IgAN) has met its primary endpoint and the full data has been published in The Lancet.

Citius reaches 92 milestone events in phase 3 catheter-related bloodstream infections trial

14-Aug-2023 By Liza Laws

Patients suffering from catheter-related bloodstream infections could be treated with Citius Pharmaceuticals antibiotic lock solution after it achieved 92 milestone events in its phase 3 trial.

Soft mist inhaler for PAH result of joint venture between Thaerapy and Resyca

19-Jun-2023 By Liza Laws

A soft mist inhaler made by Resyca BV, a joint venture of Medspray Pharma BV and Recipharm AB, is being brought to patients with pulmonary arterial hypertension (PAH).

CorMedix on track to put an end to infection misery for dialysis patients

08-Jun-2023 By Liza Laws

An antifungal and antimicrobial solution could put an end to the discomfort of infection that many patients with kidney disease often endure.

Health authority approval given to Omya for API production

27-Apr-2023 By Liza Laws

Swiss company Omya’s production site in Kemalpaşa, Turkey, has gained health authority approval to produce GMP-compliant pharmaceutical ingredients.

Roquette opens $25m US oral dosage innovation center

24-Apr-2023 By Ben Hargreaves

The French company announces the opening of its facility, and the hiring of research scientists and formulation specialists that will staff the site.

Chiesi sponsors provider of US lab spaces for networking potential

24-Apr-2023 By Ben Hargreaves

Chiesi partners with BioLabs to gain access to certain sites and work with the companies using the facilities to advance rare disease research.

Self-testing at home kits cut waiting time and ease pressure on health services, 2San says

18-Apr-2023 By Liza Laws

Diagnostic and digital tools company, 2San, has been listed with LLoydsPharmacy to offer seven health tests customers can do at home.

Interview: How to avoid unnecessary legwork and data scraping with Aerona's modern approach across pharma divisions

18-Apr-2023 By Liza Laws

Aerona Clinical is a medium sized pharmaceutical company, represented not only in the United Kingdom, but in Europe, and with a global reach. The company has been operating in this environment in the pharma industry for 15 to 20 years.

Taros and Welab combine to provide discovery and development services

17-Apr-2023 By Ben Hargreaves

The German and Spanish companies use their relevant expertise in conjunction to provide clients with services spanning from hit generation to pre-clinical development.

Phlow raises funds to expand its CDMO capabilities

12-Apr-2023 By Ben Hargreaves

The CDMO completes a Series B capital raise, and it will use the funds generated to broaden its commercial offerings through its cdmoX program.

Avacta opens two US sites and doses first patient in sarcoma drug trial

06-Apr-2023 By Liza Laws

TWO US clinical investigator sites have been opened for a phase 1 clinical trial for patients with soft tissue sarcoma and the first patient has been dosed.

Mixed results from latest study of BenevolentAI's dermatitis ointment

06-Apr-2023 By Liza Laws

An ointment for patients with mild to moderate skin disease, atopic dermatitis (AD), has had mixed results from its phase 2a study.

FDA grants approval for OTC opioid overdose treatment

03-Apr-2023 By Ben Hargreaves

The naloxone hydrochloride nasal spray will be made available over-the-counter, therefore not requiring a prescription, in an effort to reduce deaths from opioid abuse.

Cingulate and Indegene announce agreement for lead ADHD drug - the first of its kind

31-Mar-2023 By Liza Laws

An agreement has been reached to promote Cingulate Inc’s ‘first true entire active day medication’ designed to treat attention deficit hyperactivity disorder (ADHD).

Hovione and Laxxon partner on 3D printed pharmaceuticals

27-Mar-2023 By Ben Hargreaves

The two companies enter into a long-term partnership to advance 3D screen printing technologies for applications within the pharma industry.

AbbVie receives CRL over drug delivery device

27-Mar-2023 By Ben Hargreaves

The US FDA demanded more information about the device, which would deliver ABBV-951 to patients, should the treatment be approved.

Zebra adds new environmental sensors for pharma supply chain

23-Mar-2023 By Ben Hargreaves

The company launches its new ZS300 sensor, ZB200 bridge and Android sensor discovery app, which will be made available for use with the supply chains of the pharma and food industries.

Vaxart reduces workforce and pauses COVID-19 vaccine development

20-Mar-2023 By Ben Hargreaves

The developer of oral vaccines announces a restructure of its business priorities, as it looks to conserve cash to progress its norovirus candidate.

EDSA outlines supply danger to 100 medicines after manufacturer bankruptcy

20-Mar-2023 By Ben Hargreaves

Earlier this year, Akorn Pharmaceuticals fell into bankruptcy, and now an alliance of stakeholders have released a report outlining potential supply disruption to a number of medications.

Bluepharma invests €30M in industrial unit for oncology drugs

20-Mar-2023 By Liza Laws

Portuguese pharma company, Bluepharma, has opened an industrial unit specializing in producing oral solid, high potent drugs in the oncology area.

CatSci Ltd and AGC Pharma Chemicals announce their strategic partnership

16-Mar-2023 By Liza Laws

Medicine developer, CatSci Ltd announced yesterday (March 15) that it has formed a new partnership with AGC Pharma Chemicals, a small molecule Contract Development and Manufacturing Organisation (CDMO).

LG Chem targets becoming top 20 oncology company

14-Mar-2023 By Ben Hargreaves

After completing the acquisition of Aveo, the Korean chemical company wants its subsidiary to become a global leader in the therapeutic area within five years.

Janssen dual action tablet for prostate cancer gets recommended marketing authorization

13-Mar-2023 By Liza Laws

Small molecule drug, Niraparib combined with abiraterone acetate (AA) and prednisone (P) significantly reduces the risk of disease progression, or death, in patients with a type of prostate cancer, a consultant in Spain has said.